SCHEMBL20726766

SCHEMBL20726766

Fc1ccc(-c2nc(-c3cccc(-c4ccnc5c4ccc4cccnc45)c3)nc(-c3cccc(-c4ccnc5c4ccc4cccnc45)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
CCR1 P32246 2/20 0.43
CCR5 P51681 2/20 0.43
CCR8 P51685 2/20 0.43
TOP1 P11387 3/20 0.42
BRD4 O60885 1/20 0.42
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TOP2A P11388 1/20 0.41
GMNN O75496 1/20 0.40
TP53 P04637 1/20 0.40
HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20726740 0.91 CCR1 (0.49) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20732514 0.90 CCR1 (0.43) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20726768 0.90 CCR1 (0.46) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20726739 0.90 CCR1 (0.48) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20726799 0.87 TOP1 (0.44) L3MBTL1CCR1CCR8TOP1KDM4E
SCHEMBL20726838 0.87 CCR1 (0.46) L3MBTL1CCR1CCR5CCR8BRD4
SCHEMBL20726848 0.86 CCR1 (0.47) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20726771 0.86 CCR1 (0.47) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20726808 0.85 CCR1 (0.43) L3MBTL1CCR1CCR5CCR8TOP1
SCHEMBL20726793 0.85 CCR1 (0.46) L3MBTL1CCR1CCR5CCR8TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3441391-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2020-09-02 EP disclosed
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 US disclosed
EP-3441391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, CYP1A1, CRY1 L3MBTL1 370/4885CCR1 2508/4885CCR5 4041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.